Contact
searchSearch
HMP Global

Overactive Bladder News

News
FDA Approves Drug Combo for Overactive Bladder
05/09/2018
The FDA has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
The FDA has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
The FDA has approved a...
05/09/2018
Pharmacy Learning Network
News
Increased Risk for Overactive Bladder With Idiopathic Parkinson Disease
03/26/2018
According to a recent study published in PLoS ONE, idiopathic Parkinson disease may be independently associated with an increased risk of overactive bladder.
According to a recent study published in PLoS ONE, idiopathic Parkinson disease may be independently associated with an increased risk of overactive bladder.
According to a recent study...
03/26/2018
Annals of Long-Term Care
News
Vibegron Relieves Overactive Bladder Symptoms
02/23/2018
A selective beta3-adrenoreceptor agonist improves symptoms and quality of life in patients with overactive bladder, a study suggests.
A selective beta3-adrenoreceptor agonist improves symptoms and quality of life in patients with overactive bladder, a study suggests.
A selective beta3-adrenoreceptor...
02/23/2018
Pharmacy Learning Network
News
Fesoterodine Treatment for Overactive Bladder in Older Women With and Without Hypertension
09/16/2016
Researchers from Japan assessed the efficacy and safety of fesoterodine vs placebo in elderly females with OAB symptoms, including urgent urinary incontinence and with or without concomitant HT in a post-hoc analysis.
Researchers from Japan assessed the efficacy and safety of fesoterodine vs placebo in elderly females with OAB symptoms, including urgent urinary incontinence and with or without concomitant HT in a post-hoc analysis.
Researchers from Japan assessed...
09/16/2016
Annals of Long-Term Care
News
Update on Treatments for Overactive Bladder
11/24/2015
Management of overactive bladder often involves behavioral strategies such as fluid schedules, timed voiding, and bladder-holding techniques aided by strengthening the pelvic floor. These strategies are not always adequate, however.
Management of overactive bladder often involves behavioral strategies such as fluid schedules, timed voiding, and bladder-holding techniques aided by strengthening the pelvic floor. These strategies are not always adequate, however.
Management of overactive bladder...
11/24/2015
Annals of Long-Term Care
News
Treatment of Overactive Bladder with Onabotulinumtoxin-A in Elderly Patients With Central Nervous System Disorders
12/15/2014
Onabotulinumtoxin-A (BoNT-A) is prescribed to treat both overactive bladder (OAB) and urinary incontinence due to detrusor overactivity associated with neurologic conditions in adult patients who have had an inadequate response to treatment...
Onabotulinumtoxin-A (BoNT-A) is prescribed to treat both overactive bladder (OAB) and urinary incontinence due to detrusor overactivity associated with neurologic conditions in adult patients who have had an inadequate response to treatment...
Onabotulinumtoxin-A (BoNT-A) is...
12/15/2014
Annals of Long-Term Care
News
Liposomal Botulinum Toxin Shows Promise in Treating Refractory Overactive Bladder
05/26/2014
Intravesical instillation of liposomal onabotulinumtoxinA may be a promising, minimally-invasive approach for treatment of refractory overactive bladder, according to a new study.
Intravesical instillation of liposomal onabotulinumtoxinA may be a promising, minimally-invasive approach for treatment of refractory overactive bladder, according to a new study.
Intravesical instillation of...
05/26/2014
Pharmacy Learning Network
News
Mirabegron Safe and Effective for Overactive Bladder in Older Patients
04/15/2014
Mirabegron offers an alternative to antimuscarinic drugs for older patients with overactive bladder, according to pooled data from several clinical trials.
Mirabegron offers an alternative to antimuscarinic drugs for older patients with overactive bladder, according to pooled data from several clinical trials.
Mirabegron offers an alternative...
04/15/2014
Pharmacy Learning Network

Visit Our Other Brands

Pediatrics Learning Network
Surgery Learning Network
Obsetrics

 

In the News

News
Prostate Medication Recalled
07/25/2024
Jolynn Tumolo
Viatris Inc. is recalling more than 16 000 bottles of Cardura XL (doxazosin) extended-release tablets for failing to meet impurity/degradation specifications.
Viatris Inc. is recalling more than 16 000 bottles of Cardura XL (doxazosin) extended-release tablets for failing to meet impurity/degradation specifications.
Viatris Inc. is recalling more...
07/25/2024
Pharmacy Learning Network
News
Adjuvant Endoscopic Balloon Cryoablation Demonstrates Safety, Efficacy in Non–Muscle-Invasive Bladder Cancer
12/20/2022
Allison Casey
Endoscopic balloon cryoablation was found to be noninferior to a single instillation of intravesical chemotherapy following transurethral resection for non–muscle-invasive bladder cancer, according to results of a phase 2 trial.
Endoscopic balloon cryoablation was found to be noninferior to a single instillation of intravesical chemotherapy following transurethral resection for non–muscle-invasive bladder cancer, according to results of a phase 2 trial.
Endoscopic balloon cryoablation...
12/20/2022
Oncology
News
Mirabegron Reduces Urinary Frequency, Improves Overactive Bladder Symptoms After Brachytherapy for Prostate Cancer
05/23/2022
Janelle Bradley
Mirabergon added to tamsulosin improves frequent urination and overactive bladder symptoms among patients with prostate cancer who received brachytherapy, according to findings from a randomized trial.
Mirabergon added to tamsulosin improves frequent urination and overactive bladder symptoms among patients with prostate cancer who received brachytherapy, according to findings from a randomized trial.
Mirabergon added to tamsulosin...
05/23/2022
Oncology
News
Treatment Reduces Urinary Oxalate Excretion in Primary Hyperoxaluria Type 1
02/23/2022
Jolynn Tumolo
Urinary oxalate was reduced to normal or near-normal levels in patients with primary hyperoxaluria type 1 after 6 months of treatment, according to study authors.
Urinary oxalate was reduced to normal or near-normal levels in patients with primary hyperoxaluria type 1 after 6 months of treatment, according to study authors.
Urinary oxalate was reduced to...
02/23/2022
First Report Managed Care
News
Overdiagnosis of Urinary Tract Infections by Nursing Home Clinicians
01/14/2022
Samantha Matthews
Findings show an overdiagnosis of urinary tract infections by nursing home clinicians, which is causing the need for systems-based interventions to augment clinical decision-making.
Findings show an overdiagnosis of urinary tract infections by nursing home clinicians, which is causing the need for systems-based interventions to augment clinical decision-making.
Findings show an overdiagnosis...
01/14/2022
Annals of Long-Term Care
News
NH Staff Intervention Reduces Antibiotic Overprescribing for UTIs
07/30/2021
Maria Asimopoulos
There were fewer antibiotic prescriptions for urinary tract infections (UTIs) per resident in nursing homes where an intervention was implemented to improve UTI education and communication among staff members.
There were fewer antibiotic prescriptions for urinary tract infections (UTIs) per resident in nursing homes where an intervention was implemented to improve UTI education and communication among staff members.
There were fewer antibiotic...
07/30/2021
Annals of Long-Term Care
News
More Than a Third of Nursing Home UTIs Involve Antibiotic-Resistant Pathogen
08/20/2020
Researchers found that nine pathogens were behind roughly 90% of all urinary tract infections in nursing homes between 2013 and 2017, according to the National Healthcare Safety Network Long-Term Care Facility Component.
Researchers found that nine pathogens were behind roughly 90% of all urinary tract infections in nursing homes between 2013 and 2017, according to the National Healthcare Safety Network Long-Term Care Facility Component.
Researchers found that nine...
08/20/2020
Annals of Long-Term Care
News
Incidence of Urinary Incontinence in OAs With Diabetes
06/22/2018
Presenters of a study at the ADA 2018 Scientific Sessions during the Saturday poster session sought to assess urinary incontinence and related risk factors in older adults with diabetes.
Presenters of a study at the ADA 2018 Scientific Sessions during the Saturday poster session sought to assess urinary incontinence and related risk factors in older adults with diabetes.
Presenters of a study at the ADA...
06/22/2018
Annals of Long-Term Care
News
How Oral Antibiotics Impact Kidney Stone Risk
05/11/2018
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk...
05/11/2018
Pharmacy Learning Network
News
FDA Approves Drug Combo for Overactive Bladder
05/09/2018
The FDA has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
The FDA has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
The FDA has approved a...
05/09/2018
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use